SLVM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SLVM is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The pre-market price is 38.94, the technical setup is still weak because the longer-term moving averages are bearish, and the stock-trend model points to downside over the next day, week, and month. While momentum is improving slightly, the current setup does not offer a strong long-term entry. I would not buy it now.
SLVM is trading in pre-market at 38.94, near the first resistance zone at 39.28 and below the next resistance at 40.25. MACD is positive and expanding, which is a short-term bullish sign, but RSI_6 at 58.7 is neutral and does not show strong upside momentum. More importantly, the moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend is still weak. The stock-trend estimate is also unfavorable, showing a 70% chance of declines over the next day, week, and month. This is not a strong technical buy setup.
No news in the last week means there is no fresh event-driven upside catalyst. The only mild positives are the improving MACD and the fact that some analysts still maintain Buy ratings despite lowering targets. Truist previously highlighted Sylvamo's low-cost position and favorable positioning in Europe if pulp prices rise.
Recent analyst notes turned more cautious, with RBC lowering its target twice and citing weaker Q1 results, reliability issues across mills, and ongoing problems at Nymolla. Insider selling has increased sharply, up 428.32% over the last month, which is a negative signal. Hedge funds are neutral with no strong accumulation trend. Options positioning is bearish with a high put-call open interest ratio. The stock-trend model also points to downside over multiple time frames.
No usable latest-quarter financial snapshot was provided because of a data error, so I cannot verify revenue or earnings growth from the supplied financials. Based on analyst commentary, however, the latest quarter appears to have been mixed to weak, with operational reliability issues and expectations that some problems will persist for several more quarters.
Analyst sentiment is mixed but leaning cautious. RBC cut its price target from $53 to $50 and then to $49 while keeping Sector Perform, citing weaker Q1 results and operational issues. BofA cut its target from $62 to $59 but kept a Buy rating. Truist initiated with a Buy and $54 target, pointing to Sylvamo's low-cost position. Overall, Wall Street still sees some value, but target cuts and the Sector Perform stance show less enthusiasm than before, so the pros view is mixed rather than strongly bullish.
